Clinical Trial Update: Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Zenocutuzumab in patients with molecularly defined cancers, including non-small cell lung cancer with NRG1 fusion and metastatic cast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Zenocutuzumab (zenocutuzumab)

Snippet

Sponsor: Merus B.V. | Conditions: NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: TERMINATED